Avanir Pharmaceuticals (AVNR)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
18-Dec-14 8:55 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 18-Dec-14Market Sale (Planned) 5,780$16.93$97,855.40(5%)
114.58K to 108.8K
< 1%
22-Dec-14 8:07 PM
View: 
Siffert Joao Md
SVP, R&D
Avanir Pharmaceuticals (AVNR) 18-Dec-14Payment of Exercise 19,204$16.99$326,276.00(6%)
348.9K to 329.7K
< 1%
22-Dec-14 8:07 PM
View: 
Siffert Joao Md
SVP, R&D
Avanir Pharmaceuticals (AVNR) 18-Dec-14Option Exercise 32,291$2.59$83,633.7010%
316.61K to 348.9K
22-Dec-14 8:07 PM
View: 
Siffert Joao Md
SVP, R&D
Avanir Pharmaceuticals (AVNR) 18-Dec-14Market Option Sale (Planned) 15,505$16.93$262,500.00(5%)
329.7K to 314.19K
< 1%
18-Dec-14 8:52 AM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 17-Dec-14Market Sale (Planned) 62,520$16.93$1,058,460.00(6%)
976.77K to 914.25K
< 1%
18-Dec-14 8:55 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 16-Dec-14Market Option Sale (Planned) 30,000$16.94$508,200.00(21%)
144.58K to 114.58K
< 1%
18-Dec-14 8:55 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 16-Dec-14Option Exercise 30,000$3.52$105,525.0026%
114.58K to 144.58K
18-Dec-14 8:52 AM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 15-Dec-14Market Option Sale (Planned) 195,160$16.95$3,307,960.00(16%)
1.19M to 996.77K
< 1%
18-Dec-14 8:52 AM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 15-Dec-14Market Sale (Planned) 20,000$16.95$339,000.00(2%)
996.77K to 976.77K
< 1%
18-Dec-14 8:52 AM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 15-Dec-14Option Exercise 195,160$1.61$314,396.0020%
996.77K to 1.19M
28-Nov-14 9:00 PM
View: 
Palekar Rohan
SVP & Chief Commercial Officer
Avanir Pharmaceuticals (AVNR) 28-Nov-14Market Sale (Planned) 15,000$15.00$225,000.00(5%)
317.81K to 302.81K
(< 1%)
12-Nov-14 10:00 PM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 10-Nov-14Grant 361,174----57%
635.6K to 996.77K
12-Nov-14 10:00 PM
View: 
Palekar Rohan
SVP & Chief Commercial Officer
Avanir Pharmaceuticals (AVNR) 10-Nov-14Grant 94,056----42%
223.75K to 317.81K
12-Nov-14 10:00 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 10-Nov-14Grant 51,836----83%
62.74K to 114.58K
12-Nov-14 10:00 PM
View: 
Siffert Joao Md
SVP, R&D
Avanir Pharmaceuticals (AVNR) 10-Nov-14Grant 94,056----19%
504.34K to 598.39K
24-Oct-14 8:22 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 24-Oct-14Market Sale (Planned) 2,080$11.81$24,564.80(3%)
79.87K to 77.79K
(< 1%)
24-Oct-14 8:48 PM
View: 
Siffert Joao Md
SVP, R&D
Avanir Pharmaceuticals (AVNR) 24-Oct-14Market Sale (Planned) 8,426$11.80$99,426.80(4%)
230.98K to 222.55K
(< 1%)
24-Oct-14 8:34 PM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 24-Oct-14Market Sale (Planned) 27,567$11.76$324,188.00(4%)
760.41K to 732.85K
(< 1%)
17-Sep-14 8:44 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 15-Sep-14Market Sale (Planned) 55,000$9.45$519,750.00(41%)
134.87K to 79.87K
(21%)
17-Sep-14 8:28 PM
View: 
Palekar Rohan
SVP & Chief Commercial Officer
Avanir Pharmaceuticals (AVNR) 15-Sep-14Market Sale (Planned) 25,000$11.50$287,500.00(9%)
291.75K to 266.75K
< 1%
28-Aug-14 9:03 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 26-Aug-14Market Sale (Planned) 2,110$6.10$12,871.00(3%)
81.98K to 79.87K
(87%)
01-Aug-14 8:44 PM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 01-Aug-14Market Sale (Planned) 9,670$5.26$50,864.20(1%)
770.08K to 760.41K
(117%)
10-Jul-14 7:42 PM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 09-Jul-14Grant 20,000----3%
750.08K to 770.08K
30-May-14 8:00 PM
View: 
Siffert Joao Md
SVP, R&D
Avanir Pharmaceuticals (AVNR) 28-May-14Market Sale 13,547$5.18$70,173.50(6%)
244.53K to 230.98K
(120%)
30-May-14 8:00 PM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 28-May-14Market Sale (Planned) 442,212$5.01$2,215,480.00(37%)
1.19M to 750.08K
(127%)
16-May-14 8:00 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 16-May-14Market Sale 11,900$4.88$58,072.00(12%)
96.88K to 84.98K
(133%)
16-May-14 8:00 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 14-May-14Market Sale 25,596$5.13$131,307.00(21%)
122.48K to 96.88K
(122%)
14-Feb-14 7:59 PM
View: 
Mazzo David J
Director
Avanir Pharmaceuticals (AVNR) 12-Feb-14Grant 28,900----9%
307.49K to 336.39K
14-Feb-14 7:57 PM
View: 
Bishop Hans Edgar
Director
Avanir Pharmaceuticals (AVNR) 12-Feb-14Grant 28,900----45%
64.45K to 93.35K
14-Feb-14 7:56 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 12-Feb-14Grant 44,375----57%
78.1K to 122.48K
14-Feb-14 7:53 PM
View: 
Siffert Joao Md
SVP, R&D
Avanir Pharmaceuticals (AVNR) 12-Feb-14Grant 123,750----112%
110.23K to 233.98K
14-Feb-14 8:01 PM
View: 
Wheeler Craig A
Director
Avanir Pharmaceuticals (AVNR) 12-Feb-14Grant 28,900----8%
371.49K to 400.39K
14-Feb-14 7:52 PM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 12-Feb-14Grant 354,375----80%
445.71K to 800.08K
14-Feb-14 7:59 PM
View: 
Lyle Corinne H
Director
Avanir Pharmaceuticals (AVNR) 12-Feb-14Grant 21,700----37%
58.35K to 80.05K
14-Feb-14 8:00 PM
View: 
Podlesak Dennis
Director
Avanir Pharmaceuticals (AVNR) 12-Feb-14Grant 28,900----9%
307.49K to 336.39K
14-Feb-14 7:54 PM
View: 
Palekar Rohan
SVP & Chief Commercial Officer
Avanir Pharmaceuticals (AVNR) 12-Feb-14Grant 123,750----87%
143.0K to 266.75K
20-Dec-13 5:24 PM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 18-Dec-13Market Sale (Planned) 29,515$2.67$78,934.90(6%)
475.22K to 445.71K
(326%)
20-Dec-13 5:26 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 18-Dec-13Market Sale (Planned) 2,450$2.63$6,445.46(3%)
80.55K to 78.1K
(333%)
20-Dec-13 5:32 PM
View: 
Siffert Joao Md
SVP, R&D
Avanir Pharmaceuticals (AVNR) 18-Dec-13Market Sale (Planned) 5,970$2.63$15,713.00(5%)
116.2K to 110.23K
(333%)
19-Dec-13 4:31 PM
View: 
Palekar Rohan
SVP & Chief Commercial Officer
Avanir Pharmaceuticals (AVNR) 17-Dec-13Market Purchase 10,000$2.80$28,000.008%
133.0K to 143.0K
307%
05-Nov-13 8:01 PM
View: 
Palekar Rohan
SVP & Chief Commercial Officer
Avanir Pharmaceuticals (AVNR) 04-Nov-13Market Purchase 10,000$4.19$41,895.008%
123.0K to 133.0K
172%
05-Nov-13 8:00 PM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 01-Nov-13Market Sale (Planned) 4,385$4.14$18,137.70(< 1%)
479.61K to 475.22K
(175%)
19-Sep-13 8:50 PM
View: 
Siffert Joao Md
SVP, R&D
Avanir Pharmaceuticals (AVNR) 18-Sep-13Option Exercise 21,094$1.85$39,023.9018%
116.2K to 137.29K
19-Sep-13 8:50 PM
View: 
Siffert Joao Md
SVP, R&D
Avanir Pharmaceuticals (AVNR) 18-Sep-13Market Option Sale (Planned) 21,094$4.22$88,968.20(15%)
137.29K to 116.2K
(170%)
02-Aug-13 7:58 PM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 02-Aug-13Market Sale (Planned) 15,500$4.84$74,981.20(3%)
495.11K to 479.61K
(135%)
17-May-13 8:01 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 15-May-13Market Option Sale (Planned) 57,700$3.29$189,548.00(36%)
158.25K to 100.55K
(247%)
17-May-13 8:02 PM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 15-May-13Market Option Sale (Planned) 215,438$3.26$702,229.00(29%)
745.54K to 530.11K
(249%)
17-May-13 8:01 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 15-May-13Market Sale (Planned) 20,000$3.29$65,701.30(20%)
100.55K to 80.55K
(247%)
17-May-13 8:02 PM
View: 
Katkin Keith
President and CEO
Director
Avanir Pharmaceuticals (AVNR) 15-May-13Option Exercise 215,438$0.79$170,055.0041%
530.11K to 745.54K
17-May-13 8:01 PM
View: 
Ocampo Christine
Vice President, Finance
Avanir Pharmaceuticals (AVNR) 15-May-13Option Exercise 57,700$0.88$50,776.0057%
100.55K to 158.25K